Fresenius SE & Co. KGaA buy Snowman
Summary
This prediction ended on 27.07.22 with a price of €27.71. The price of Fresenius SE & Co. KGaA has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.49%. Dividends of €1.04 are taken into consideration when calculating the performance. Snowman has 60% into this predictionFresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Fresenius SE & Co. KGaA | 2.786% | 2.786% | 12.740% |
iShares Core DAX® | 1.665% | 0.362% | 17.556% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% |
According to Snowman what are the pros and cons of Fresenius SE & Co. KGaA for the foreseeable future?
Pros
Cons
Comments by Snowman for this prediction
In the thread Fresenius SE & Co. KGaA diskutieren
In the thread Trading Fresenius SE & Co. KGaA
Stopped prediction by Snowman for Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA
08.02.21
16.07.21
16.07.21
Fresenius SE & Co. KGaA
29.01.21
29.04.21
08.02.21
Fresenius SE & Co. KGaA
11.01.21
11.01.22
29.01.21